Atara Biotherapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ECOR1 CAPITAL, LLC | 02/14/2025 | 532,134 | $7.08 M | 13.48% | 4.98% |
REDMILE GROUP, LLC | 02/14/2025 | 441,701 | $5.88 M | -2.34% | 4.13% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 125,000 | $1.66 M | 0.26% | 1.17% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 124,473 | $1.66 M | -3.62% | 1.16% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 75,196 | $1.00 M | 0.00% | 0.70% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 67,140 | $893,633 | -0.88% | 0.63% |
BLACKROCK, INC. | 02/07/2025 | 60,846 | $809,861 | -0.18% | 0.57% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 54,744 | $728,811 | 17.17% | 0.51% |
STALEY CAPITAL ADVISERS INC | 02/07/2025 | 50,000 | $665,500 | 25.00% | 0.47% |
MARSHALL WACE, LLP | 02/13/2025 | 24,958 | $332,192 | 100.00% | 0.23% |
BIRCHVIEW CAPITAL, LP | 02/14/2025 | 22,000 | $292,820 | 100.00% | 0.21% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 14,000 | $186,340 | 0.00% | 0.13% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 10,133 | $134,870 | -94.24% | 0.09% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 3,603 | $47,956 | 100.00% | 0.03% |
02/06/2025 | 1,416 | $18,847 | 100.00% | 0.01% | |
LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 444 | $5,000 | 244.19% | 0.00% |
01/23/2025 | 240 | $3,194 | 100.00% | 0.00% | |
JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 203 | $2,702 | 100.00% | 0.00% |
02/14/2025 | 176 | $2,330 | 100.00% | 0.00% | |
RHUMBLINE ADVISERS | 01/30/2025 | 175 | $2,329 | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 70 | $932 | -90.69% | 0.00% |
POINT72 (DIFC) LTD | 02/14/2025 | 68 | $905 | 100.00% | 0.00% |
GAMMA INVESTING LLC | 01/03/2025 | 56 | $745 | 0.00% | 0.00% |
EVERSOURCE WEALTH ADVISORS, LLC | 02/10/2025 | 35 | $466 | 0.00% | 0.00% |
02/13/2025 | 28 | $373 | 100.00% | 0.00% | |
CENTIVA CAPITAL, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
GLOBAL RETIREMENT PARTNERS, LLC | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
02/10/2025 | 0 | $0 | -100.00% | 0.00% |
Atara Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 59 institutional investors and hedge funds held shares of Atara Biotherapeutics, Inc.. The most heavily invested institutionals were:
GAMMA Investing LLC: 0
EcoR1 Capital, LLC: 532,134
Redmile Group, LLC: 441,701
Vestal Point Capital, LP: 125,000
ACADIAN ASSET MANAGEMENT LLC: 124,473
TANG CAPITAL MANAGEMENT LLC: 75,196
21.92% of Atara Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.72 M shares in the last 24 months. This purchase volume represents approximately $39.93 M in transactions.